AMAM Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Ambrx Biopharma to Johnson & Johnson
08. Januar 2024 09:03 ET | Wohl & Fruchter LLP
We are investigating the fairness of the sale of Ambrx Biopharma to Johnson & Johnson.